Sterneck Capital Management Llc acquired 4,841 shares as Gilead Sciences Inc (GILD)’s stock declined 8.05%. Lmm Llc owns 15.70 million shares or 2.62% of their U.S. portfolio. Employees Retirement System Of Texas who had been investing in Gilead Sciences Inc for a number of months, seems to be bullish on the $97.54 billion market cap company. The stock increased 1.22% or $0.9 during the last trading session, reaching $74.69. About shares traded. Aetna Inc (NYSE:AET) has risen 28.84% since August 29, 2016 and is uptrending. It has underperformed by 38.50% the S&P500. Chevy Chase has invested 0.42% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) were released by: Seekingalpha.com and their article: “Mavyret Could Amplify Gilead’s HCV Pain” published on August 14, 2017 as well as Seekingalpha.com’s news article titled: “Gilead: Vosevi might provide the answer” with publication date: August 23, 2017. The stock increased 0.28% or $0.43 during the last trading session, reaching $156.53. Gamco Inc Et Al owns 12,414 shares or 0.01% of their USA portfolio. Hamilton Lane Inc (NASDAQ:HLNE) has 0.00% since August 28, 2016 and is. It has underperformed by 30.27% the S&P500. Therefore 63% are positive. On average, equities research analysts expect that Gilead Sciences will post $8.74 EPS for the current year. The company was maintained on Wednesday, August 31 by Jefferies. Wedbush has “Neutral” rating and $15.0 target. Alta Cap Management Ltd Com stated it has 0.96% in Gilead Sciences, Inc. Vetr upgraded Gilead Sciences from a “buy” rating to a “strong-buy” rating and set a $83.66 price objective on the stock in a research note on Monday, June 26th. (NASDAQ:GILD) rating on Tuesday, July 25. (NASDAQ:GILD) for 3,150 shares. Jefferies has “Hold” rating and $115 target. The firm has “Outperform” rating given on Monday, October 3 by RBC Capital Markets. Atlantic Securities initiated the stock with “Neutral” rating in Friday, December 18 report. Raymond James And Assocs reported 879,644 shares. Oppenheimer downgraded Internap Corp (NASDAQ:INAP) on Friday, September 25 to “Perform” rating.
Investors sentiment increased to 0.93 in Q4 2016. Its down 0.23, from 0.93 in 2016Q3. Numeric Lc accumulated 1.87% or 2.49 million shares. 70 funds opened positions while 146 raised stakes. Morgan Stanley reported 193,884 shares. 1,500 were reported by Ckw Fincl Gru. The biopharmaceutical company reported $2.56 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.11 by $0.45. (NYSE:NOV) for 237,000 shares. Nomura Asset Limited reported 207,718 shares. Parkside Commercial Bank reported 0.01% stake. 96,295 were accumulated by Hartford Invest Mngmt Company. Cwm Lc has invested 0.16% in Gilead Sciences, Inc. Evanston Invests Dba Evanston Advisors holds 1.73% or 78,593 shares in its portfolio. Old Second Bankshares Of Aurora holds 0.08% in National-Oilwell Varco, Inc. (NASDAQ:GILD). Toronto Dominion Financial Bank has invested 0.06% of its portfolio in Gilead Sciences, Inc. Swiss Bancshares holds 0.06% of its portfolio in National-Oilwell Varco, Inc. The company had a trading volume of 1,103,840 shares. Bluemountain Management Ltd Liability holds 0.01% or 7,804 shares. Nwq Mgmt Co Limited Company stated it has 61,056 shares.
Since March 1, 2017, it had 0 buys, and 1 insider sale for $2.07 million activity. Following the sale, the executive vice president now owns 137,488 shares of the company’s stock, valued at $10,174,112. Gilead Sciences’s dividend payout ratio is now 22.58%.
Cullen Frost Bankers Inc increased Nike Inc Class B (NYSE:NKE) stake by 11,782 shares to 294,097 valued at $14.95M in 2016Q4. SOL Capital Management CO boosted its stake in shares of Gilead Sciences by 36.4% in the first quarter. Discovery Communications (NASDAQ:DISCA) was reduced too.
Investors sentiment increased to 1.5 in 2016 Q4. Its up 0.21, from 0.7 in 2016Q3. It worsened, as 106 investors sold GILD shares while 656 reduced holdings. Finally, First PREMIER Bank raised its stake in Gilead Sciences by 69.6% in the first quarter. 950.84 million shares or 0.69% more from 944.29 million shares in 2016Q3 were reported. (NASDAQ:GILD) for 2.98 million shares.
New York Community Bancorp, Inc.is a multi-bank holding company.
Several hedge funds have recently bought and sold shares of GILD. Hodges Mngmt invested in 41,254 shares.
Southernsun Asset Management Llc holds 4.36% of its portfolio in OGE Energy Corp. for 5.10 million shares. United Asset Strategies Inc.’s holdings in Gilead Sciences were worth $5,797,000 at the end of the most recent reporting period. 8,875 are owned by Financial Counselors Inc. Royal State Bank Of Canada holds 0% of its portfolio in Internap Corp (NASDAQ:INAP) for 16,735 shares. The California-based Cornerstone has invested 0.71% in Gilead Sciences, Inc. Inc. now owns 32,687 shares of the biopharmaceutical company’s stock valued at $2,220,000 after buying an additional 2,331 shares during the period.
Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 19 have Buy rating, 0 Sell and 11 Hold. (NASDAQ:GILD) for 60,605 shares. Kelly Lawrence W And Associate Ca reported 39,450 shares.
Since March 1, 2017, it had 0 insider buys, and 7 sales for $16.39 million activity. MARTIN JOHN C also sold $5.16 million worth of Gilead Sciences, Inc. (NASDAQ:GILD). Shelter Mutual Ins has invested 1.28% in Gilead Sciences, Inc. (NASDAQ:GILD). Tiverton Asset Mgmt Limited Liability holds 0.87% or 205,539 shares in its portfolio. Also, EVP Gregg H. Alton sold 15,000 shares of the company’s stock in a transaction dated Tuesday, August 1st.